n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine has been researched along with 2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine in 1 studies
| Studies (n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine) | Trials (n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine) | Recent Studies (post-2010) (n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine) | Studies (2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine) | Trials (2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine) | Recent Studies (post-2010) (2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine) |
|---|---|---|---|---|---|
| 37 | 1 | 1 | 5 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clare, BW | 1 |
1 other study(ies) available for n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine and 2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine
| Article | Year |
|---|---|
The frontier orbital phase angles: novel QSAR descriptors for benzene derivatives, applied to phenylalkylamine hallucinogens.
Topics: Hallucinogens; Humans; Models, Molecular; Molecular Conformation; Phenethylamines; Quantum Theory | 1998 |